APH vs COHR
Amphenol and Coherent, side by side.
Prices and company dataas of yesterday's close
- APHBuy moresales growth, past year58%
Amphenol's sales grew 58% over the past year, and its report on Oct 28 beat profit forecasts by 9.6%.
- COHRBuy moresales growth, past year31%
Coherent's sales grew 31% over the past year, and it trades at 106 times its past year's earnings, below the 180 it typically traded at from May to July.
Percent return
- APH+11.33%
- COHR+48.41%
Nov 11, 2025 to Nov 11, 2026
Where they differ
- Company size: APH $194B, COHR $43.4B.
- Sales growth, 1 yr: APH +58%, COHR +31%. APH is ahead.
- Price for $1 of next year's profit: APH $21, COHR $17. COHR is ahead.
- Profit per $1 of sales: APH 29¢, COHR 14¢. APH is ahead.
- Cash minus debt: APH −$12.6B, COHR −$2.59B. COHR is ahead.
- Price change, 1 yr: APH +11%, COHR +48%. COHR is ahead. S&P 500 +12%.
- How much the price swings: APH 47%, COHR 106%. APH is ahead.
| Measure | APHAmphenol | COHRCoherent |
|---|---|---|
| Price and returns | ||
| Price | $79.31 | $234.53 |
| Today | −0.80% | Best in this row: +9.26% |
| 1 month | Best in this row: −9.09% | −24.99% |
| 3 months | Best in this row: −5.00% | −28.62% |
| This year | +17.97% | Best in this row: +27.06% |
| 1 year | +11.33% | Best in this row: +48.41% |
| 5 years | Best in this row: +300.59% | +258.69% |
| From 52-week high | −10.5% | −45.1% |
| How much it swings (90 days) | Best in this row: 47% | 106% |
| Valuation | ||
| Market value | $194B | $43.4B |
| Price vs last year's earnings | Best in this row: 45.4× | 106.2× |
| Price vs next year's expected earnings | 21.4× | Best in this row: 16.5× |
| Price vs earnings, adjusted for growth | 1.22× | Best in this row: 0.88× |
| Price to sales | 5.6× | Best in this row: 4.8× |
| Price vs cash it brings in | 36.0× | – |
| Company value vs operating profit | Best in this row: 18.0× | 24.4× |
| Price vs earnings, against its own past (0 = cheapest) | – | 0 |
| Growth | ||
| Revenue growth, 1 year | Best in this row: +57.6% | +30.8% |
| Revenue growth a year, last 3 years | Best in this row: +22.3% | +11.3% |
| Earnings per share growth, last year | +68.6% | Best in this row: +1103.2% |
| Earnings per share growth expected next year | +29.0% | Best in this row: +54.8% |
| Profitability | ||
| Kept from sales after making the product | Best in this row: 39.2% | 38.2% |
| Kept as operating profit | Best in this row: 28.7% | 14.1% |
| Kept as final profit | Best in this row: 17.9% | 12.2% |
| Kept as spare cash | Best in this row: 15.5% | −23.2% |
| Profit on shareholders' money | Best in this row: 40.1% | 9.3% |
| Profit on all money put in | Best in this row: 22.7% | 7.9% |
| Balance sheet | ||
| Net cash (cash minus debt) | −$12.6B | Best in this row: −$2.59B |
| Debt for each $1 of shareholders' money | 1.03× | Best in this row: 0.37× |
| Short-term assets per $1 of bills due | 1.94× | Best in this row: 2.29× |
| Dividend yield | 0.80% | – |
| Share of profit paid as dividends | 23% | – |
| Our readPro | ||
| Our call | Buy more | Buy more |
| Why | Amphenol's sales grew 58% over the past year, and its report on Oct 28 beat profit forecasts by 9.6%. | Coherent's sales grew 31% over the past year, and it trades at 106 times its past year's earnings, below the 180 it typically traded at from May to July. |
| Where the price sits | in the full report | in the full report |
| Our overall score (out of 100) | Best in this row: 77 | 67 |
| Our value score | Best in this row: 39 | 32 |
| Our growth score | Best in this row: 95 | 94 |
| Our quality score | Best in this row: 84 | 58 |
| Our price trend score | Best in this row: 77 | 64 |
| Earnings and analysts | ||
| Analyst consensus | Buy | Buy |
| To average analyst target | +36.8% | Best in this row: +53.1% |
| Average analyst target | $108.50 | $359.00 |
| Analysts rating it a buy | Best in this row: 90% | 85% |
| Buy ratings added, 3 months | +2 | Best in this row: +4 |
| Analysts covering | 11 | 18 |
APH: faster sales growth
Our pick of these: Amphenol
Sales growth +57.6% vs +30.8%
APH +57.6%, COHR +30.8%.Forward P/E per point of sales growth 0.37 vs 0.54
APH 0.37, COHR 0.54.Keeps 28.7% of sales as operating profit, vs 14.1%
APH 28.7%, COHR 14.1%.Where it loses: COHR has more analyst upside, +53.1% vs +36.8%
Cover this stock to see the full report
The call, its reasons and what would change it are free for everyone. The price zones, the whole brief and how the call has moved come with covering a stock. Use one of your three covered slots, or go Pro for every stock.
Prices as of yesterday, 3:59 PM ET. A view, not advice.